Covered recipient · General Payments record
DAVID L DAY
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2021–2024
$904.80
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $355.28 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $301.17 | 16 |
| PFIZER INC. | $36.65 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.80 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611886 | CMS |
| ABBVIE INC. | $20.41 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611888 | CMS |
| ABBVIE INC. | $25.61 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611890 | CMS |
| ABBVIE INC. | $5.41 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611892 | CMS |
| ABBVIE INC. | $13.96 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611894 | CMS |
| ABBVIE INC. | $23.70 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611896 | CMS |
| ABBVIE INC. | $5.52 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611898 | CMS |
| ABBVIE INC. | $27.82 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611900 | CMS |
| ABBVIE INC. | $29.84 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611902 | CMS |
| ABBVIE INC. | $20.66 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611904 | CMS |
| ABBVIE INC. | $25.58 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611906 | CMS |
| ABBVIE INC. | $17.47 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611908 | CMS |
| ABBVIE INC. | $11.28 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611910 | CMS |
| ABBVIE INC. | $15.75 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611912 | CMS |
| ABBVIE INC. | $21.36 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611914 | CMS |
| ABBVIE INC. | $18.00 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611916 | CMS |
| Novartis Pharmaceuticals Corporation | $17.46 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086882911 | CMS |
| PFIZER INC. | $19.36 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131970048 | CMS |
| PFIZER INC. | $17.29 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131018273 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.